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cWhen you cannot measure it, . . . your knowledge
is of a meagre and unsatisfactory kind; it
may be the beginning of knowledge, but you
have scarcely . . . advanced to the state of Science,
whatever the matter may be.
—Kelvin (1)
In 1951, Gorlin and Gorlin (2) proposed the
hydraulic orifice equation, based on the simple
formula that orifice area equals flow divided by
velocity.
A  F/V [1]
Their idea was to calculate orifice area of stenotic
heart valves from measurements of flow and veloc-
ity. Flow could be assessed by indicator-dilution
methods, but velocity could not be measured be-
cause Doppler ultrasound had not yet been in-
vented. Therefore, the Gorlins proposed to calcu-
See page 1088
late velocity from the pressure gradient, using the
Torricelli law. For most of the 6 decades since their
seminal paper, the Gorlin equation has been used to
calculate the orifice area in mitral and aortic steno-
sis. Levine and Gaasch (3) showed that the Gorlin
equation could be used to calculate regurgitant
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Bracco Diagnostics.olume (RgV) in regurgitant lesions such as mitral
egurgitation (MR):
RgV  ROA  Cd  MPG  T [2]
n Equation 2, ROA is regurgitant orifice area, Cd
s a discharge coefficient accounting for energy loss,
MPG is the square root of the mean pressure
radient, and T is the time over which regurgitation
ccurs. Equations 1 and 2 can be rewritten as
ollows:
ROA  RgV/VTI [3]
here RgV is regurgitant volume in milliliters and
TI is the velocity-time integral of the regurgitant
et in centimeters, as determined by Doppler ultra-
ound. VTI incorporates the mean gradient and the
uration of regurgitant flow and is primarily deter-
ined by the systolic pressure difference between
he left ventricle (LV) and left atrium (LA). VTI is
ndependent of MR severity and generally falls
ithin a fairly narrow range of values (except in
cute MR, where the pressure gradient between the
V and LA is low). Thus, the 2 primary determi-
ants of MR severity are ROA and RgV, which are
inearly related. RgV can also be expressed as
egurgitant fraction (RgF), which is the percentage
f the total stroke output of the LV that is ejected
etrograde into the LA. According to both the Amer-
can Society of Echocardiography (4) and the Amer-
can College of Cardiology/American Heart Associa-
ion guidelines (5), ROA, RgV, and RgF are used
ogether to determine MR severity.
In this issue of iJACC, Buchner et al. (6), report
ifferences in the shape of the ROA in patients with
R of different etiologies. The investigators used
ine cardiac magnetic resonance (CMR) to directly
isualize the ROA in 74 patients with MR due to
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1098varying causes. MR severity was classified as mild
(n  29), moderate (n  20), or severe (n  25)
using RgF calculated by CMR. Etiology of MR was
considered degenerative in 19 patients, leaflet pro-
lapse in 15, flail leaflet in 25, and functional
(secondary to LV dysfunction) in 15. The term
“degenerative” was used unconventionally in this
study to describe thickened, scarred leaflets, which
are usually due to rheumatic heart disease, other
post-inflammatory conditions, or anorectic drug
use. The term “degenerative” is usually reserved for
prolapse or flail leaflets due to myxomatous degen-
eration of leaflet and subvalvular tissues. Despite
this faux pas, the investigators show convincingly
that ROA is seldom circular in MR, but is elliptical
or slitlike, particularly in functional MR. ROA
shape index, defined as the long-axis divided by the
short-axis of the elliptical ROA, was significantly
larger for functional MR (3.9) than for mitral valve
prolapse (2.1), flail (2.2), or “degenerative” etiology
(1.2). Given that orifice shape is not a component
of the hydraulic orifice equation, and therefore not
a primary determinant of MR severity, is this
finding clinically relevant?
To answer this question, one must consider that
echocardiography has become the clinical standard
for assessing MR severity. In clinical practice, MR
severity is most often graded by “eyeballing” the size
of regurgitant jet in the LA using color Doppler
imaging. This is unfortunate because this method
has been known to be inaccurate for 2 decades and
is discouraged in the American Society of Echocar-
diography guidelines (4). In a recent report from
our institution, almost one-half of patients referred
for percutaneous treatment of severe MR with the
MitraClip device (Abbott Vascular, Abbott Park,
Illinois), did not have severe MR (7). The size of
the color Doppler regurgitant jet within the LA is
dependent on too many variables, including instru-
ment settings, hemodynamics, jet eccentricity, and
orifice geometry (4). With regard to the latter,
slitlike orifices are analogous to placing one’s thumb
over a water hose, creating a spray that may appear
very large on color Doppler imaging. Moreover,
when MR occurs through 2 separate orifices, color
Doppler jets appear larger than would be expected
for a single orifice of the same area (8). A good
example of both situations is the bileaflet mechan-
ical prosthetic valve, in which 3 separate regurgitant
jets are seen in the LA during systole. Sometimes,
these jets can appear fairly large, yet clinicians know
that this is “trace” or “physiological” MR, and jet
size is ignored.Because of the known limitations of regurgitant
jet area in evaluating MR severity, efforts have
focused on imaging the ROA, either by vena
contracta measurement, or by calculation from the
size of the proximal isovelocity surface area (PISA)
region (4). The vena contracta is the high velocity
flow stream at or just downstream to the ROA. It
conforms to ROA shape but is slightly smaller.
Vena contracta width is a 1-dimensional measure-
ment of the diameter of the ROA, which can be
misleading if the ROA is not round. The vena
contracta should be measured in a long-axis view,
perpendicular to the largest diameter of the ellipti-
cal ROA (9). PISA calculation assumes a hemi-
spheric shape to the proximal flow convergence
region, which is only true for relatively round orifice
shapes. Slitlike orifice shapes, such as those seen in
functional MR, do not have a hemispheric PISA,
which leads to underestimation of ROA (10,11).
Even when vena contracta and PISA are carefully
performed, significant interobserver variability ex-
ists in grading MR severity (12). Clearly, the best
way to measure ROA is direct visualization by
3-dimensional (3D) imaging techniques. This has
been done successfully with both 3D echocardiog-
raphy (13–16) and with CMR (17).
Despite the ability to directly image the regurgi-
tant orifice by CMR or 3D echocardiography, there
are still challenges to overcome. Both methods use
tomographic slices that are oriented 3 dimension-
ally. The actual ROA may curve out of the imaging
plane. If there is more than 1 ROA, they may not
be in the exact same imaging plane. Imaging
artifacts such as Doppler blooming or CMR flow
voids can be problematic. Temporal resolution must
also be considered. In holosystolic MR, the ROA is
dynamic and should ideally be measured as a mean
value over systole. In mitral prolapse, MR may
occur only in late systole, such that a single frame
image of the ROA may significantly overestimate
MR severity. Thus, it is important to consider both
RgV and ROA to get a complete understanding of
the severity of MR.
CMR provides a comprehensive evaluation of
MR. ROA and RgV are the primary mathematical
determinants of MR severity, and both can be
measured quantitatively by CMR (18). In addition,
LV volumes and ejection fraction are important in
MR (5), and CMR is generally accepted as the most
robust and reproducible clinical method for mea-
suring them. Functional MR is a disease of the LV,
in which structurally normal leaflets are restricted
by ventricular enlargement, regional wall motion
sb
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1099abnormalities, and/or symmetrical or asymmetrical
annular dilation. As shown in the Buchner et al.
study (6), CMR offers the ability to measure leaflet
tenting area, tethering distance, and the mitral
annulus. Thus, CMR can evaluate the mechanism
and severity of MR, as well as its impact on the LV.
Since the publication of the Sellers angiographic
criteria (19), MR severity has been assessed quali-
tatively. Published guidelines (4,5) even recom-
mend converting the quantitative measure of ROA,
RgV, and RgF into descriptive categories such as
mild, moderate, severe, or 1 to 4 on an ordinalgitation by transesophageal echocardi-
1
1
1
1
1
Three-dimensional cclinically meaningful (“mild” vs. “severe” MR), we
now have imaging tools capable of accurate mea-
surement of the quantitative, mathematical deter-
minants of MR severity. To fully understand the
complex pathophysiology of MR and evaluate new
surgical or percutaneous therapies, it is important to
be able to measure MR quantitatively.
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urn, Baylor Heart and Vascular Institute, 621 North
all Street, Suite H030, Dallas, Texas 75226. E-mail:cale. Even though such descriptive categories are paulgr@baylorhealth.edu.R E F E R E N C E S
1. Kelvin. Available at: http://en.
w i k i quo t e . o r g /w i k i /Wi l l i am_
Thomson. Accessed August 15, 2011.
2. Gorlin R, Gorlin SG. Hydraulic for-
mula for calculation of the area of the
stenotic mitral valve, other cardiac
valves, and central circulatory shunts.
Am Heart J 1951;41:1–29.
3. Levine HJ, Gaasch WH. Vasoactive
drugs in chronic regurgitant lesions of
the mitral and aortic valves. J Am Coll
Cardiol 1996;28:1083–91.
4. Zoghbi W, Enriquez-Sarano M, Fos-
ter E, et al., for the American Society
of Echocardiography. Recommenda-
tions for evaluation of the severity of
native valvular regurgitation with two-
dimensional and Doppler echocardi-
ography. J Am Soc Echocardiogr
2003;16:777–802.
5. Bonow RO, Carabello BA, Chatterjee
K, et al. ACC/AHA 2006 guidelines
for the management of patients with
valvular heart disease: a report of the
American College of Cardiology/
American Heart Association Task
Force on Practice Guidelines (Writing
Committee to Revise the 1998 Guide-
lines for the Management of Patients
With Valvular Heart Disease. J Am
Coll Cardiol 2006;114:e84–231.
6. Buchner S, Poschenreider F, Hamer
OW, et al. Direct visualization of
regurgitant orifice by CMR reveals
differential asymmetry according to
etiology of mitral regurgitation. J Am
Coll Cardiol Img 2011;4:1088–96.
7. Grayburn P, Roberts BJ, Aston S, et al.
Mechanism and severity of mitral regur-ography in patients referred for percuta-
neous valve repair. Am J Cardiol 2011;
108:882–7.
8. Lin BA, Forouhar AS, Pahlevan NM,
et al. Color Doppler jet area overesti-
mates regurgitant volume when mul-
tiple jets are present. J Am Soc Echo-
cardiogr 2010;23:993–1000.
9. Roberts BJ, Grayburn PA. Color flow
imaging of the vena contracta in mi-
tral regurgitation: technical consider-
ations. J Am Soc Echocardiogr 2003;
16:1002–6.
0. Yosefy C, Levine RA, Solis J, et al.
Proximal flow convergence region as
assessed by real-time 3-dimensional
echocardiography: challenging the
hemispheric assumption. J Am Soc
Echocardiogr 2007;20:389–96.
1. Rifkin RD, Sharma S. An alternative
isovelocity surface model for quantita-
tion of effective regurgitant orifice area
in mitral regurgitation with an elon-
gated orifice application to functional
mitral regurgitation. J Am Coll Car-
diol Img 2010;3:1091–103
2. Biner S, Rafique A, Rafii F, et al.
Reproducibility of proximal isoveloc-
ity surface area, vena contracta, and
regurgitant jet area for assessment of
mitral regurgitation severity. J Am
Coll Cardiol Img 2010;3:235–43.
3. Kahlert P, Plicht B, Schenk IM, Janosi
A, Erbel R, Buck T. Direct assessment
of size and shape of non-circular vena
contracta area in functional versus or-
ganic mitral regurgitation using real-
time three-dimensional echocardiogra-
phy. J Am Soc Echocardiogr 2008;21:
912–21.
4. Little SH, Pirat B, Kumar R, et al.
olor Doppler echo-cardiography for direct measurement of
vena contracta area in mitral regurgita-
tion: in vitro validation and clinical ex-
perience. J Am Coll Cardiol Img 2008;
1:695–704.
15. Yosefy C, Hung J, Chua S, et al.
Direct measurement of vena contracta
area by real-time 3-dimensional echo-
cardiography for assessing severity of
mitral regurgitation. Am J Cardiol
2009;104:978–83.
16. Zeng X, Levine RA, Hua L, et al.
Diagnostic value of vena contracta
area in the quantitation of mitral re-
gurgitation severity by color Doppler
3D echocardiography. Circ Cardio-
vasc Imaging 2011 Jul 5 [E-pub ahead
of print].
17. Buchner S, Debi K, Poschenreider F,
et al. Cardiovascular magnetic reso-
nance for direct assessment of ana-
tomic regurgitant orifice in mitral re-
gurgitation. Circ Cardiovasc Imaging
2008;1:148–55.
18. HundleyWG, Li HF,Willard JE, et al.
Magnetic resonance imaging assess-
ment of the severity of mitral regurgita-
tion: comparison with invasive tech-
niques. Circulation 1995;92:1151–8.
19. Sellers RD, Levy MJ, Amplatz K,
Lillehei CW. Left retrograde cardio-
angiography in acquired cardiac dis-
ease: technic, indications, and inter-
pretation in 700 cases. Am J Cardiol
1964;14:437–47.
Key Words: cardiac magnetic
resonance y mitral valve y
regurgitant orifice y
regurgitation.
